HCMT
AZN icon

Highland Capital Management (Texas)’s AstraZeneca AZN Stock Holding History

Highland Capital Management (Texas)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-822,950
Closed -$45M – 287
2016
Q4 		$45M Buy
822,950
+601,950
+272% +$34.2M 2.11% 6
2016
Q3 		$14.5M Buy
+221,000
New +$14.4M 0.44% 51

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Highland Capital Management (Texas)'s AZN Position: Q2 2019 in Review

Highland Capital Management (Texas) increased its AstraZeneca (AZN) stake by 50% in Q2 2019, buying an estimated $196K and bringing the position to 7,500 shares worth $619K. The position accounts for 0.04% of the portfolio, ranked #239.

Highland Capital Management (Texas) first reported a position in AZN in Q1 2016 and has held it in 9 quarters since. The position peaked at $27.8M in Q3 2016. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

  • Highland Capital Management (Texas) held 7,500 shares of AstraZeneca worth $619K as of Q2 2019.
  • Highland Capital Management (Texas) bought 2,500 AstraZeneca shares in Q2 2019, an estimated $196K.
  • AstraZeneca made up 0.04% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #239 holding.
  • Highland Capital Management (Texas) first reported a position in AstraZeneca in Q1 2016 and has held it in 9 quarters since.
  • Highland Capital Management (Texas)'s AstraZeneca position peaked at $27.8M in Q3 2016.
  • 546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.